BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11114501)

  • 1. Caspases: key players in programmed cell death.
    Grütter MG
    Curr Opin Struct Biol; 2000 Dec; 10(6):649-55. PubMed ID: 11114501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atomic-resolution structure of human caspase-8, a key activator of apoptosis.
    Watt W; Koeplinger KA; Mildner AM; Heinrikson RL; Tomasselli AG; Watenpaugh KD
    Structure; 1999 Sep; 7(9):1135-43. PubMed ID: 10508785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity.
    Wei Y; Fox T; Chambers SP; Sintchak J; Coll JT; Golec JM; Swenson L; Wilson KP; Charifson PS
    Chem Biol; 2000 Jun; 7(6):423-32. PubMed ID: 10873833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspases as targets for anti-inflammatory and anti-apoptotic drug discovery.
    Talanian RV; Brady KD; Cryns VL
    J Med Chem; 2000 Sep; 43(18):3351-71. PubMed ID: 10978183
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
    Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
    Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells.
    Jiang C; Wang Z; Ganther H; Lu J
    Cancer Res; 2001 Apr; 61(7):3062-70. PubMed ID: 11306488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and zymogen activation of caspases.
    Donepudi M; Grütter MG
    Biophys Chem; 2002 Dec; 101-102():145-53. PubMed ID: 12487996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling apoptosis by inhibition of caspases.
    Concha NO; Abdel-Meguid SS
    Curr Med Chem; 2002 Mar; 9(6):713-26. PubMed ID: 11945133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of the caspases.
    Stennicke HR; Salvesen GS
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):17-31. PubMed ID: 9748481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspases: pharmacological manipulation of cell death.
    Lavrik IN; Golks A; Krammer PH
    J Clin Invest; 2005 Oct; 115(10):2665-72. PubMed ID: 16200200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis.
    Nicholson DW
    Nat Biotechnol; 1996 Mar; 14(3):297-301. PubMed ID: 9630889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase 8: igniting the death machine.
    Salvesen GS
    Structure; 1999 Oct; 7(10):R225-9. PubMed ID: 10545333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
    Pereira NA; Song Z
    Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
    Blanchard H; Donepudi M; Tschopp M; Kodandapani L; Wu JC; Grütter MG
    J Mol Biol; 2000 Sep; 302(1):9-16. PubMed ID: 10964557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase inhibitors: viral, cellular and chemical.
    Callus BA; Vaux DL
    Cell Death Differ; 2007 Jan; 14(1):73-8. PubMed ID: 16946729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unified model for apical caspase activation.
    Boatright KM; Renatus M; Scott FL; Sperandio S; Shin H; Pedersen IM; Ricci JE; Edris WA; Sutherlin DP; Green DR; Salvesen GS
    Mol Cell; 2003 Feb; 11(2):529-41. PubMed ID: 12620239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitors.
    Ekert PG; Silke J; Vaux DL
    EMBO J; 1999 Jan; 18(2):330-8. PubMed ID: 9889190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
    Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
    Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
    von Haefen C; Wieder T; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2003 Apr; 22(15):2236-47. PubMed ID: 12700660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspases, the enemy within, and their role in oxidative stress-induced apoptosis of inner ear sensory cells.
    Van De Water TR; Lallemend F; Eshraghi AA; Ahsan S; He J; Guzman J; Polak M; Malgrange B; Lefebvre PP; Staecker H; Balkany TJ
    Otol Neurotol; 2004 Jul; 25(4):627-32. PubMed ID: 15241246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.